Searched for
UTI HEALTHCARE
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...- Crude oil shock clouds near-term outlook, but FY27 earnings growth still intact: Karthikraj LakshmananUTI AMC's Karthikraj Lakshmanan sees cautiously optimistic Indian market outlook with intact FY27 earnings trajectory, despite near-term cr...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Mutual funds raise tech exposure in March after 8-year low. Tactical move or trend reversal?Mutual funds raised tech exposure in March after an eight-year low, driven by tactical rebalancing and improved valuations. Experts say glo...
- Tom Brady-backed telehealth firm eMed valued at over $2 billion in latest funding roundTelehealth company eMed has secured $200 million in funding, boosting its valuation to over $2 billion. This investment will fuel the devel...
- Cranberries are great for diabetes and liver health: Now experts say this antioxidant-packed superfood has a surprising new benefit tooCranberries are gaining renewed attention for their potential role in preventing urinary tract infections, supported by emerging research a...
- Fund Manager Talk | UTI AMC’s Amit Premchandani explains why FII selling isn’t the full story for marketsDespite foreign investor concerns, UTI AMC's Amit Premchandani sees value in Indian equities, emphasizing valuations and earnings quality o...
- Fund Manager Talk | Asset allocation model suggesting 60-65% in stocks: UTI Mutual Fund's Amit PremchandaniWe do not predict market levels, what we focus on is valuations which are still above average. Small and mid-cap are expensive while large ...
- Pharma, healthcare sector mutual funds deliver up to 44% return in 2024. Should you increase allocation?Pharma and healthcare mutual funds have yielded impressive returns in 2024. The sector benefited from resilience amidst corrections in othe...
- ETMarkets Fund Manager Talk: This Rs 8,600 crore manager sees opportunities in 3 sectors to bet on domestic themeV Srivatsa of UTI Asset Management discusses investment opportunities in domestic themes like private sector banking, auto sector, and heal...
- New India-UK research to trial easy-to-use test to cut antibiotic resistanceDOSA2, as the latest phase is known, is coordinated by the University of Edinburgh and includes partners at the University of the Arts Lond...
- Kotak Healthcare Fund, two other NFOs open for subscription this week; should you invest?Three mutual fund NFOs or new fund offers are open for subscription this week. Kotak Healthcare Fund, DSP Banking & Financial Services Fund...
- UTI Mutual Fund launches UTI Innovation FundAnkit Agarwal, Fund Manager, UTI AMC, said, “UTI Innovation Fund marks a significant step forward for investors in navigating the ever-grow...
- IIT Guwahati researchers develop 3D printed cost-effective device for rapid diagnosis of UTIThe details of the Point-Of-Care testing (POCT) prototype have been published in reputed peer-reviewed journal ACS Applied Bio Materials. T...
- Sun Pharma’s best day in 16 months boosts July show of pharma fundsNet asset values of ICICI Prudential Healthcare and Diagnostics, Nippon India Pharma Fund, Tata India Pharma & Healthcare Fund, UTI Healthc...
- Smallcaps, midcaps to outperform Nifty; pharma earnings may surprise: V Srivatsa, UTI MFV Srivatsa, Executive Vice President & Fund Manager at UTI Mutual Fund, says it makes no sense to take a blind call that the top 50 compani...
- Private equity firm Ascent Capital scouts for $400 mn for next fundThe new fund, which is targeting a final close by the end of the year, will take the total assets under management of the Bengaluru-based i...
- Pharma Funds: Defensive bet for your portfolioWith deteriorating global and domestic investment climate, investors are looking out for defensive bets. And Pharma funds are one such cate...
Load More
